Publication Month: Aug 2021 | Report Code: TIPRE00024270 | No. of Pages: 135 | Category: Chemicals and Materials | Status: Published
Metal Nanoparticles have exceptional properties such as high aspect ratio and uniform size. They are used in a wide spectrum of applications, such as catalysis, medical, and energy storage. The metal nanoparticles have various applications in end-use industries, such as pharmaceuticals and healthcare, chemical, cosmetics, and electrical and electronics.
In 2020, North America accounted for the largest share in the market. The increase in the development of the pharmaceutical and the healthcare sectors and a rise in demand for sustainable energy resources have increased the demand for metal nanoparticles in North America. Owing to the presence of developed countries, such as the US and Canada, and conducive government support for R&D activities, countries in the region explore and produce innovative products. Furthermore, the advancements in the medical technology and increased investments in the healthcare sector have propelled the demand for metal nanoparticles in the medical industry. Along with this, the presence of domestic and international metal nanoparticles companies in the region created lucrative opportunities for the metal nanoparticle market in the region.
The ongoing COVID-19 pandemic has had a significant impact on the metal nanoparticles market. The outbreak has distorted operational efficiency and disrupted the value chains due to the sudden shutdown of national and international boundaries, which has created revenue loss and damage. The disruptions in the production and supply chain have had a negative impact on the metal nanoparticles market. The implementation of lockdown in various countries along with travel restrictions has lessened the global supply of products along with a reduced logistic operation. Research has been ongoing for the utilization of gold nanoparticles for COVID-19 testing kits, which will provide the results in minutes. In the US, a group of researchers at the University of Maryland claimed that they have developed a diagnostic test that can detect the novel coronavirus that causes COVID-19 within 10 minutes and the results will be visible with naked eyes. The test is a simple colorimetry-based assay, which uses gold nanoparticles that are capped with the nucleic acid sequence of the nucleocapsid phosphoprotein of the SARS-COV-2 virus. Along with this, Sugentech, Inc. (a company in Republic of Korea) developed SGTi-flex COVID-19 IgM/IgG test kit, which is a gold nanoparticle-based immunochromatographic test kit that determines COVID-19’s IgM and IgG antibodies. The test helps in determining the antibodies that are specific proteins, which are developed in response to the infection. Thus, an increased usage of gold nanoparticles in the healthcare sector is having a positive impact on the metal nanoparticles market.
In the medical industry, metal nanoparticles are increasingly being used in therapeutic agents, drug delivery, bioimaging, and cancer diagnostics as well as treatment, among other applications. Various types of metal nanoparticles, including silver, titanium, gold, platinum, and copper, are known for their potential therapeutic effects. Gold and silver nanoparticles effectively inhibit the growth of gram-negative and gram-positive bacteria. Gold nanoparticles are used to detect biomarkers in the diagnosis of infectious diseases, cancer, and heart diseases. Platinum nanoparticles are used in biomedical applications such as implants, imaging, photothermal therapy, and drug delivery due to their intrinsic antimicrobial, antioxidant, and anticancer properties. Titanium nanoparticles are being used for killing bacteria present on various surfaces. When exposed to ultraviolet radiations, these nanoparticles produce a strong oxidative effect and act as photocatalytic disinfectants. Silver nanoparticles have antimicrobial and anticancer properties, and they are increasingly being used in the production of wound coatings and device coatings. Copper nanoparticles are being used in medical sector for the protection, control, and treatment of infections. Thus, a surge in the application of various metal nanoparticles in the medical industry is driving the metal nanoparticles market.
|Market Size Value in||US$ 25,373.92 Million in 2020|
|Market Size Value by||US$ 81,567.38 Million by 2028|
|Growth rate||CAGR of 15.9% from 2021-2028|
|No. of Pages||135|
|No. of Tables||56|
|No. of Charts & Figures||76|
|Historical data available||Yes|
|Segments covered||Metal and End-Use Industry|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
A few of the key market players operating in the metal nanoparticles market are American Elements; BBI Group; EPRUI Biotech Co. Ltd.; Meliorum Technologies, Inc.; Nanocomposix; Nanosc, Inc.; Nanostructured and Amorphous Materials, Inc.; Nanoshel LLC.; TANAKA HOLDINGS Co., Ltd.; and US Research Nanomaterials INC. Major players in the market adopt strategies such as mergers and acquisitions and product launches to expand the geographic presence and consumer base.
The List of Companies - Metal Nanoparticles Market